Advancing perovskite solar cell technologies toward their theoretical power conversion efficiency (PCE) requires delicate control over the carrier dynamics throughout the entire device. By controlling the formation of the perovskite layer and careful choices of other materials, we suppressed carrier recombination in the absorber, facilitated carrier injection into the carrier transport layers, and maintained good carrier extraction at the electrodes. When measured via reverse bias scan, cell PCE is typically boosted to 16.6% on average, with the highest efficiency of ~19.3% in a planar geometry without antireflective coating. The fabrication of our perovskite solar cells was conducted in air and from solution at low temperatures, which should simplify manufacturing of large-area perovskite devices that are inexpensive and perform at high levels.
Background: The coronavirus disease 2019 outbreak is evolving rapidly worldwide. Objective: To evaluate the risk of serious adverse outcomes in patients with COVID-19 by stratifying the comorbidity status. Methods: We analysed data from 1590 laboratory confirmed hospitalised patients from 575 hospitals in 31 provinces/autonomous regions/provincial municipalities across mainland China between 11 December 2019 and 31 January 2020. We analysed the composite end-points, which consisted of admission to an intensive care unit, invasive ventilation or death. The risk of reaching the composite end-points was compared according to the presence and number of comorbidities. Results: The mean age was 48.9 years and 686 (42.7%) patients were female. Severe cases accounted for 16.0% of the study population. 131 (8.2%) patients reached the composite end-points. 399 (25.1%) reported having at least one comorbidity. The most prevalent comorbidity was hypertension (16.9%), followed by diabetes (8.2%). 130 (8.2%) patients reported having two or more comorbidities. After adjusting for age and smoking status, COPD (HR (95% CI) 2.681 (1.424-5.048)), diabetes (1.59 (1.03-2.45)), hypertension (1.58 (1.07-2.32)) and malignancy (3.50 (1.60-7.64)) were risk factors of reaching the composite end-points. The hazard ratio (95% CI) was 1.79 (1.16-2.77) among patients with at least one comorbidity and 2.59 (1.61-4.17) among patients with two or more comorbidities. Conclusion: Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes. This article has supplementary material available from
Cancer is a disease driven by genetic variation and mutation. Exome sequencing can be utilized for discovering these variants and mutations across hundreds of tumors. Here we present an analysis tool, VarScan 2, for the detection of somatic mutations and copy number alterations (CNAs) in exome data from tumor-normal pairs. Unlike most current approaches, our algorithm reads data from both samples simultaneously; a heuristic and statistical algorithm detects sequence variants and classifies them by somatic status (germline, somatic, or LOH); while a comparison of normalized read depth delineates relative copy number changes. We apply these methods to the analysis of exome sequence data from 151 high-grade ovarian tumors characterized as part of the Cancer Genome Atlas (TCGA). We validated some 7790 somatic coding mutations, achieving 93% sensitivity and 85% precision for single nucleotide variant (SNV) detection. Exome-based CNA analysis identified 29 large-scale alterations and 619 focal events per tumor on average. As in our previous analysis of these data, we observed frequent amplification of oncogenes (e.g., CCNE1, MYC) and deletion of tumor suppressors (NF1, PTEN, and CDKN2A). We searched for additional recurrent focal CNAs using the correlation matrix diagonal segmentation (CMDS) algorithm, which identified 424 significant events affecting 582 genes. Taken together, our results demonstrate the robust performance of VarScan 2 for somatic mutation and CNA detection and shed new light on the landscape of genetic alterations in ovarian cancer.
Sun is the largest carbon-neutral energy source that has not been fully utilized. Although there are solar cell devices based on inorganic semiconductor to efficiently harvest solar energy, the cost of these conventional devices is too high to be economically viable. This is the major motivation for the development of organic photovoltaic (OPV) materials and devices, which are envisioned to exhibit advantages such as low cost, flexibility, and abundant availability.[1] The past success in organic light-emitting diodes provides scientists with confidence that organic photovoltaic devices will be a vital alternate to the inorganic counterpart.At the heart of the OPV technology advantage is the easiness of the fabrication, which holds the promise of very low-cost manufacturing process. A simple, yet successful technique is the solution-processed bulk heterojunction (BHJ) solar cell composed of electron-donating semiconducting polymers and electron-withdrawing fullerides as active layers.[2] The composite active layer can be prepared as a large area in a single step by using techniques such as spin-coating, inkjet-printing, spraycoating, gravure-coating, roller-casting etc.[3] In the last fifteen years, a significant progress has been made on the improvement of the power-conversion efficiency (PCE) of polymer BHJ solar cells, and the achieved efficiencies have evolved from less than 1% in the poly(phenylene vinylene) (PPV) system in 1995,[2] to 4-5% in the poly(3-hexylthiphene) (P3HT) system in 2005, [4] to around 6%, as reported recently.[5] However, the efficiency of polymer solar cells is still significantly lower than their inorganic counterparts, such as silicon, CdTe and CIGS, which prevents practical applications in large scale.There are many factors limiting the performance of the BHJ solar cells.[6] Among them, the properties of materials of the active layer are the most determining factor in the overall performances of polymer solar cells. [7] Ideally, the polymers should have a broad absorption in the solar spectrum to ensure effective harvesting of the solar photons and a high chargecarriers mobility for charge transport. Further, suitable energy levels of the polymer are required that match those of the fullerides. The polymer should have a low-lying highest occupied molecular orbital (HOMO) energy level to provide a large open-circuit voltage (V oc ) and a suitable lowest unoccupied molecular orbital (LUMO) energy level to provide enough offset for charge separation. In addition, morphology of the active composite layer plays a very important role. It is imperative that a bicontinuous network with a domain width approximately twice that of the exciton diffusion length and a high donor/acceptor interfaces is formed, which favors the exciton dissociation and transport of the separated charges to the respective electrode. [8] Most of the polymers reported to date are far from ideal to fulfill all these requirements. [9] We have developed a series of novel semiconducting polymers based on alternating e...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.